{"gene":"GDF5","run_date":"2026-04-28T18:06:52","timeline":{"discoveries":[{"year":2005,"finding":"GDF5 shows pronounced binding specificity for BMPR-IB over BMPR-IA (approximately 12-fold higher affinity), and a single residue, Arg57 in the pre-helix loop, is solely responsible for this high binding specificity to BMPR-IB. The variant GDF5-R57A binds BMPR-IA and BMPR-IB with comparable high affinity.","method":"Biosensor analysis (SPR), structural analysis, and site-directed mutagenesis","journal":"Journal of molecular biology","confidence":"High","confidence_rationale":"Tier 1 — in vitro binding assays with mutagenesis and structural validation in a single rigorous study","pmids":["15890363"],"is_preprint":false},{"year":1999,"finding":"GDF5 is necessary and sufficient for both cartilage development and restriction of joint formation to appropriate locations in digit development. Loss-of-function brachypodism mice show reduced limb bone length, altered joint and sternum formation, and reduced digit bone number; recombinant GDF5 applied to developing chick and mouse limbs induces ectopic cartilage and restricts joint site.","method":"Mouse loss-of-function genetics (brachypodism mutant analysis), recombinant protein application to chick and mouse limb explants","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 — multiple genetic and functional rescue approaches, replicated across species","pmids":["10208739"],"is_preprint":false},{"year":1997,"finding":"A dominant-negative mutation in CDMP1/GDF5 (substituting the first conserved cysteine in the mature domain with tyrosine) results in a protein that is not secreted, is inactive in vitro, and prevents secretion of other related BMP family members, likely through heterodimer formation.","method":"In vitro secretion assay, dominant-negative co-expression assay, heterodimer formation analysis","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 1 — in vitro functional assays with mechanistic follow-up (heterodimer formation) in a well-cited study","pmids":["9288098"],"is_preprint":false},{"year":2004,"finding":"Ror2 (tyrosine kinase receptor) and BMPR-IB (BRI-b, serine/threonine kinase receptor) form a ligand-independent heteromeric complex requiring the frizzled-like CRD domain of Ror2. Within this complex, Ror2 is transphosphorylated by BRI-b. Ror2 modulates GDF5 signaling by inhibiting Smad1/5 signaling and activating a Smad-independent pathway, both required for chondrogenic differentiation.","method":"Co-immunoprecipitation, transphosphorylation assays, luciferase reporter assays (Smad pathway), dominant-negative constructs in ATDC5 cells, epistasis analysis in Ror2/BRI-b/Gdf5 deficient mouse crosses","journal":"Genes to cells","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP, functional signaling assays, and genetic epistasis across multiple orthogonal methods","pmids":["15569154"],"is_preprint":false},{"year":2009,"finding":"Two GDF5 mutations (N445K, N445T) identified in multiple synostosis syndrome patients cause resistance to the BMP antagonist NOGGIN due to substitution at residue N445, which lies within overlapping receptor and antagonist interfaces. This NOGGIN resistance results in gain-of-function, causing massive ectopic cartilage induction in vivo. Residue N445 is highly conserved among BMPs except BMP9 and BMP10, which naturally carry lysine at this position and are similarly NOGGIN-insensitive.","method":"Chicken micromass culture chondrogenesis assay, in vivo chick ectopic expression, site-directed mutagenesis, functional BMP9 variant engineering","journal":"PLoS genetics","confidence":"High","confidence_rationale":"Tier 1–2 — in vitro and in vivo functional assays with mutagenesis and mechanistic follow-up","pmids":["19956691"],"is_preprint":false},{"year":2013,"finding":"A GDF5 point mutation (W414R) simultaneously causes gain-of-function (NOGGIN resistance, leading to SYNS2) and loss-of-function (reduced signaling via BMPR-IA, leading to BDA1) through a dual pathomechanism, as the mutation lies within the overlapping antagonist and receptor binding interface of GDF5.","method":"Chondrogenesis assays with primary mesenchymal cells, luciferase reporter gene assays, Surface Plasmon Resonance (SPR) binding analysis","journal":"PLoS genetics","confidence":"High","confidence_rationale":"Tier 1 — multiple orthogonal quantitative methods (SPR, reporter assays, functional differentiation assays) in one study","pmids":["24098149"],"is_preprint":false},{"year":2012,"finding":"The GDF5 mutation S94N, located in the BMPR-II interaction site (knuckle epitope), impairs BMPR-II binding, reduces Smad and non-Smad signaling, and decreases chondrogenic differentiation of ATDC5 cells, but causes gain-of-function in mouse micromass cultures due to strongly reduced affinity for the antagonist NOGGIN, resulting in the SYNS phenotype.","method":"SPR binding assays, reporter gene assays, ALP assay, qPCR, ATDC5 and mouse micromass chondrogenesis assays","journal":"Journal of bone and mineral research","confidence":"High","confidence_rationale":"Tier 1 — multiple quantitative orthogonal methods establishing dual receptor and antagonist binding mechanism","pmids":["21976273"],"is_preprint":false},{"year":2016,"finding":"The crystal structure of Gremlin-2 (a DAN-family BMP antagonist) in complex with GDF5 at 2.9-Å resolution reveals two Grem2 dimers binding perpendicularly to each GDF5 monomer in an H-like structure. The dynamic Grem2 N-terminus undergoes conformational change upon binding to simultaneously interact with both type I and type II receptor motifs on GDF5, blocking signaling. DAN-family members can interact with BMP type I receptor complexes, whereas Noggin outcompetes the type I receptor.","method":"X-ray crystallography (2.9-Å resolution), SPR binding studies, structural comparison","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 1 — crystal structure with binding validation and mechanistic comparison across antagonist families","pmids":["27524626"],"is_preprint":false},{"year":2008,"finding":"GDF5 promotes chondroprogenitor cell aggregation by increasing cell adhesiveness and enhances skeletal element growth by increasing proliferation within epiphyseal cartilage. GDF5 acts at two distinct stages: promoting initial chondrogenesis via cell adhesion promotion, and increasing skeletal element size via proliferation.","method":"Chick embryo retroviral overexpression (RCAS), micromass and single-cell suspension cultures of limb mesenchymal cells, autoradiography of S-phase cells, histological analysis","journal":"The Journal of bone and joint surgery. American volume","confidence":"High","confidence_rationale":"Tier 2 — in vivo overexpression combined with in vitro mechanistic studies showing cell adhesion increase","pmids":["11263662"],"is_preprint":false},{"year":1999,"finding":"CDMP-1/GDF5 overexpression in transgenic mice promotes mesenchymal cell recruitment, increases number of chondroprogenitor cells, and accelerates chondrocyte differentiation to hypertrophy; expression in the notochord inhibits vertebral body formation by blocking sclerotome cell migration, antagonizing ventralization signals from the notochord.","method":"Transgenic mouse overexpression with histological and phenotypic analysis","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 — clean transgenic gain-of-function with specific cellular phenotypic readouts","pmids":["9885252"],"is_preprint":false},{"year":2004,"finding":"GDF5, in contrast to BMP4, increases the number of prechondrogenic mesenchymal cell condensations and promotes chondroprogenitor cell aggregation without inducing internodular cells toward chondrogenesis; GDF5 causes a more sustained elevation of Sox9 and a transient (not sustained) increase in Col10 expression, indicating distinct mechanisms from BMP4.","method":"Mouse embryonic limb bud mesenchyme micromass cultures with comparative BMP4/GDF5 treatment, gene expression analysis","journal":"Journal of cellular biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 — systematic comparative functional study but single lab","pmids":["15048875"],"is_preprint":false},{"year":2008,"finding":"GDF5 signals through the Alk6 (BMPR-IB) receptor to enhance Trps1 protein levels and p38 MAPK phosphorylation and nuclear translocation in chondrogenic cells; Trps1 acts downstream of GDF5 signaling to promote chondrocyte differentiation and apoptosis. Dominant-negative Alk6 blocks GDF5-induced Trps1 upregulation and differentiation.","method":"ATDC5 cell treatment with GDF5, dominant-negative Alk6 construct, SB203580 p38 inhibitor, western blot, Trps1 overexpression/knockdown","journal":"Genes to cells","confidence":"Medium","confidence_rationale":"Tier 2 — epistasis with DN receptor and inhibitor, single lab","pmids":["18363966"],"is_preprint":false},{"year":2009,"finding":"GDF5 and BMP2 prevent apoptosis induced by serum starvation in mouse embryonic fibroblasts via BMPR2, which stabilizes XIAP by stimulating BMPR2-XIAP interaction and reducing XIAP ubiquitination; increased XIAP then counteracts apoptosis by binding and inactivating activated caspases. This mechanism is independent of Smad and MAPK signaling.","method":"Cell viability assays, Co-IP (BMPR2-XIAP interaction), ubiquitination assays, caspase activity assays, BMPR2-deficient cell analysis","journal":"Biochimica et biophysica acta","confidence":"Medium","confidence_rationale":"Tier 2 — Co-IP and functional mechanism established, single lab","pmids":["19782107"],"is_preprint":false},{"year":2007,"finding":"The rs143383 T/C SNP in the 5' UTR of GDF5 (located in the core promoter) exerts allelic differences in transcriptional activity in chondrogenic cells, with the OA susceptibility T allele showing reduced promoter activity.","method":"Luciferase reporter assays in chondrogenic cell lines","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 2 — functional reporter assays replicated across populations, highly cited foundational study","pmids":["17384641"],"is_preprint":false},{"year":2007,"finding":"The OA-susceptibility T allele of rs143383 shows up to 27% reduction in GDF5 expression relative to the C allele in vivo in articular cartilage of OA patients, confirming that the functional effect of this regulatory SNP is active in joint tissue.","method":"Allelic expression analysis of RNA extracted from OA patient cartilage (in vivo differential allelic expression assay)","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 — direct in vivo allelic expression quantification in patient tissue, replicates in vitro finding","pmids":["17616513"],"is_preprint":false},{"year":2009,"finding":"The transcription factor DEAF-1 binds differentially to the two alleles of rs143383 in the GDF5 5'UTR and acts as a trans-acting repressor of GDF5 expression; a second polymorphism in the 3'UTR also independently influences allelic expression of GDF5.","method":"Electrophoretic mobility shift assay (EMSA), luciferase reporter assays, allelic expression analysis in multiple joint tissue types","journal":"Arthritis and rheumatism","confidence":"Medium","confidence_rationale":"Tier 2–3 — EMSA plus allelic expression, single lab","pmids":["19565498"],"is_preprint":false},{"year":2013,"finding":"Four trans-acting factors—Sp1, Sp3, P15, and DEAF-1—bind to the GDF5 5'UTR at the rs143383 locus. Sp1, Sp3, and DEAF-1 are repressors of GDF5 expression; DEAF-1 represses the T allele of rs143383 to a significantly greater extent than the C allele, contributing to differential allelic expression. Sp1 and DEAF-1 together have the greatest repressive activity.","method":"Competition and supershift EMSAs, oligonucleotide pulldown with quantitative mass spectrometry, ChIP, RNAi knockdown, and overexpression","journal":"PLoS genetics","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods including in vivo ChIP and MS identification, single lab","pmids":["23825960"],"is_preprint":false},{"year":2014,"finding":"CpG methylation at the +37 site within the SP1/SP3 binding site modulates the allele-specific binding of SP1 and SP3 to rs143383, attenuating the repressive effects of SP1, SP3, and DEAF-1 on GDF5 promoter activity. The +37 CpG site is differentially methylated between osteoarthritic hip and knee cartilage, potentially explaining knee-specific OA susceptibility.","method":"Bisulfite sequencing, demethylation agent treatment, EMSA, luciferase reporter assays, comparative cartilage methylation analysis","journal":"Human genetics","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods establishing methylation-dependent allele-specific transcription factor binding","pmids":["24861163"],"is_preprint":false},{"year":2011,"finding":"DNA methylation of the GDF5 promoter and 5'UTR regulates GDF5 expression; demethylation correlates with increased GDF5 expression. The CpG sites created by the C alleles at rs143383 and rs143384 are variably methylated, and demethylating agent treatment further increases allelic expression imbalance between C and T alleles.","method":"Bisulfite sequencing of cell lines and joint tissues, demethylating agent (5-azacytidine) treatment, allelic expression quantification","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 — epigenetic mechanism established with demethylating agent experiment and in vivo tissue analysis","pmids":["21642387"],"is_preprint":false},{"year":2013,"finding":"SOX11 directly binds conserved SOX family binding sites in the 5'UTR region of the GDF5 gene and activates GDF5 expression in vitro and in chick micromass cultures. SOX11 overexpression in developing chick limbs enhances (but does not ectopically induce) Gdf5 expression.","method":"Reporter gene assays, micromass cell cultures, chromatin binding assays (SOX11 binding to GDF5 5'UTR), RCAS viral overexpression in chick limbs","journal":"BMC developmental biology","confidence":"Medium","confidence_rationale":"Tier 2–3 — direct binding demonstrated with reporter assays and in vivo overexpression, single lab","pmids":["23356643"],"is_preprint":false},{"year":2016,"finding":"Separate modular enhancers in the Gdf5 locus control joint-specific expression in axial versus limb joints and in specific subsets of composite joints; predicted transcription factor binding sites within these enhancers are required for expression in particular joints. Functional rescue tests in mice confirm that large flanking regions (>100 kb including up- and downstream sequences) are required for normal joint formation and patterning.","method":"Systematic regulatory element survey using transgenic mice, in vivo enhancer functional rescue assays","journal":"PLoS genetics","confidence":"High","confidence_rationale":"Tier 2 — systematic in vivo enhancer mapping with functional rescue in transgenic mice","pmids":["27902701"],"is_preprint":false},{"year":2017,"finding":"A novel downstream regulatory region (GROW1) is required for normal Gdf5 expression at the ends of developing bones and for normal bone lengths in vivo. A human GROW1 common base-pair change decreases enhancer activity and colocalizes with peaks of positive selection; the derived allele is found in Neandertals and Denisovans.","method":"Transgenic mouse regulatory survey, in vivo Gdf5 expression analysis, enhancer activity assays","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 2 — in vivo functional enhancer knockout and expression rescue in transgenic mice","pmids":["28671685"],"is_preprint":false},{"year":2016,"finding":"Joints develop through a continuous influx of Gdf5-positive cells into the interzone, which contribute differentially to forming joint tissues including articular cartilage, capsule, and ligaments. Early labeling of Gdf5-positive interzone cells fails to mark the entire joint organ, while multiple Cre activation steps show contribution to various compartments over time.","method":"Knockin Gdf5-CreERT2 mouse lineage tracing with temporal Cre activation steps and tdTomato reporter","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 — genetic lineage tracing with multiple temporal labeling steps and reporter, rigorous in vivo approach","pmids":["27292641"],"is_preprint":false},{"year":2013,"finding":"GDF5 stimulation of human chondrocytes inhibits canonical Wnt signaling through upregulation of the Wnt inhibitors DKK1 and FRZB, and GDF5-mediated inhibition of MMP13 expression is specifically mediated by DKK1. GDF5 also upregulates anabolic genes ACAN and SOX9 and inhibits ADAMTS4.","method":"Human chondrocyte pellet mass culture, qPCR, ELISA, canonical Wnt stimulation (Wnt3a/CHIR-99021) and DKK1 blockade (WAY-262611) experiments","journal":"Osteoarthritis and cartilage","confidence":"Medium","confidence_rationale":"Tier 2 — pharmacological pathway dissection with multiple interventions, single lab","pmids":["24561281"],"is_preprint":false},{"year":2013,"finding":"BMP2 and GDF5 induce neuronal differentiation (neurite outgrowth) of SH-SY5Y human neuronal cells via a direct mechanism dependent on BMP type I receptor activation of canonical Smad1/5/8 signaling.","method":"SH-SY5Y cell culture, neurite outgrowth assay, BMP receptor inhibition, Smad1/5/8 phosphorylation assay","journal":"Molecular and cellular neurosciences","confidence":"Medium","confidence_rationale":"Tier 2 — direct signaling pathway established with receptor inhibition and Smad phosphorylation readout, single lab","pmids":["23831389"],"is_preprint":false},{"year":2008,"finding":"A GDF5 mutation (p.L373R in the prodomain) allows secretion of mature GDF5 protein and causes proximal symphalangism (gain-of-function/altered function), while a different mutation (p.Y487X truncating the C-terminus) prevents secretion of mature GDF5 and causes brachydactyly type C (loss-of-function), demonstrating that distinct parts of the GDF5 protein govern distinct functional outcomes.","method":"Transfection of COS-7 cells with WT and mutant GDF5 cDNAs, western blot of conditioned medium for mature GDF5 protein detection","journal":"Journal of human genetics","confidence":"Medium","confidence_rationale":"Tier 3 — in vitro secretion assay with two contrasting mutations, single method but clear mechanistic distinction","pmids":["18283415"],"is_preprint":false},{"year":2007,"finding":"A novel ENU-induced GDF5 mutation (W408R) in a highly conserved region of the active signaling domain produces a protein that is secreted and dimerizes normally but inhibits wild-type GDF5 in a dominant-negative fashion, causing severe skeletal abnormalities and early-onset osteoarthritis in mice.","method":"ENU mutagenesis screen, secretion assay, dimerization assay, in vivo skeletal phenotyping including OA assessment","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 — biochemical characterization of dominant-negative mechanism with in vivo phenotypic validation","pmids":["17656374"],"is_preprint":false},{"year":2015,"finding":"TGF-β1 and GDF5 synergistically drive nucleopulpogenic differentiation of human adipose stromal cells; Smad2/3 signaling mainly governs acquisition of NP cell molecular identity while Smad1/5/8 controls NP cell morphology during this differentiation process.","method":"Human adipose stromal cell differentiation, gene expression analysis, Smad pathway inhibition, in vivo transplantation in nude mice","journal":"Stem cells","confidence":"Medium","confidence_rationale":"Tier 2 — Smad pathway dissection with in vivo validation, single lab","pmids":["26661057"],"is_preprint":false},{"year":2020,"finding":"Gdf5 upregulation in articular cartilage and synovium following joint injury requires downstream regulatory sequence of the Gdf5 locus; in progenitors, Gdf5 expression is inversely correlated with YAP expression, and YAP overexpression suppresses Gdf5 expression in chondroprogenitors in vitro.","method":"Gdf5-LacZ reporter mouse lines, DMM experimental OA model, acute cartilage injury model, YAP overexpression in chondroprogenitors","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo reporter analysis combined with in vitro YAP overexpression functional test, single lab","pmids":["31932746"],"is_preprint":false},{"year":2019,"finding":"CaVβ1E (an embryonic isoform of the CaV1.1 β subunit) boosts downstream GDF5 signaling to counteract muscle loss after denervation; aged muscle expresses lower CaVβ1E and shows an altered GDF5-dependent response to denervation. CaVβ1E overexpression improves mass wasting in aging muscle by increasing GDF5 expression.","method":"Sciatic denervation mouse model, Dnmt3a-KO mice, CaVβ1E overexpression, muscle mass and gene expression analysis","journal":"Science translational medicine","confidence":"Medium","confidence_rationale":"Tier 2 — genetic loss- and gain-of-function with mechanistic link to GDF5, single lab","pmids":["31694926"],"is_preprint":false},{"year":2018,"finding":"Dnmt3a methylates the Gdf5 promoter in satellite cells; loss of Dnmt3a leads to reduced Gdf5 promoter methylation, markedly increased Gdf5 mRNA expression, suppressed satellite cell differentiation, and impaired skeletal muscle regeneration. Treatment with DNA methylation inhibitor azacytidine also increases Gdf5 expression in wild-type satellite cells.","method":"Skeletal muscle-specific Dnmt3a-KO mice, microarray analysis, promoter methylation analysis, azacytidine treatment, satellite cell differentiation assays","journal":"FASEB journal","confidence":"Medium","confidence_rationale":"Tier 2 — KO mouse model with methylation analysis and pharmacological validation, single lab","pmids":["29146735"],"is_preprint":false},{"year":2016,"finding":"miR-7 directly targets GDF5 in nucleus pulposus cells; miR-7 overexpression enhances IL-1β-induced extracellular matrix degeneration, while inhibition of miR-7 prevents this, an effect that is reversed by GDF5 siRNA. This establishes GDF5 as a downstream mediator of miR-7 action on disc ECM.","method":"Dual-luciferase reporter assay (direct 3'UTR targeting), gain- and loss-of-function with miR-7 mimic/antagomiR, GDF5 siRNA rescue","journal":"Biomedicine & pharmacotherapy","confidence":"Medium","confidence_rationale":"Tier 2–3 — direct 3'UTR luciferase validation plus functional rescue, single lab","pmids":["27583982"],"is_preprint":false},{"year":2004,"finding":"GDF5 deficiency in mice results in altered collagen fibril size distribution (increased proportion of medium-diameter fibrils at the expense of larger fibrils) in tail tendons, leading to altered time-dependent mechanical behavior (slower stress-relaxation), suggesting GDF5 regulates collagen fibril assembly in tendon.","method":"Electron microscopy ultrastructural analysis, biomechanical testing of GDF5-/- vs. control littermate tail tendons","journal":"Connective tissue research","confidence":"Medium","confidence_rationale":"Tier 2 — KO mouse with ultrastructural and biomechanical phenotype, single lab","pmids":["11913489"],"is_preprint":false},{"year":2006,"finding":"GDF5 treatment of rat medial collateral ligament injury increased collagen fibril diameter in repair tissue, enhanced type I procollagen expression, and reduced type III procollagen relative to type I, with decorin and fibromodulin expression also relatively reduced against type I collagen, explaining increased fibril diameter and improved biomechanical strength.","method":"Rat MCL gap injury model, transmission electron microscopy, quantitative PCR, in situ hybridization, biomechanical testing","journal":"Journal of orthopaedic research","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo model with multi-method mechanistic readouts linking GDF5 to collagen fibril regulation","pmids":["16419971"],"is_preprint":false},{"year":2003,"finding":"GDF5 regulates connexin 43 (Cx43) expression and enhances chondrogenesis in a gap junction-dependent manner, with concordant mRNA expression profiles of GDF5 and Cx43 during embryonic development in limb, spine, and heart.","method":"Expression correlation analysis during embryogenesis, functional studies linking GDF5 action to gap junction activity","journal":"The anatomical record","confidence":"Low","confidence_rationale":"Tier 3 — expression correlation with partial functional follow-up, single lab","pmids":["14613311"],"is_preprint":false}],"current_model":"GDF5 is a secreted BMP-family ligand that signals primarily through BMPR-IB (with a single residue, Arg57, determining its high receptor-binding specificity) and BMPR-IA, activating canonical Smad1/5/8 and non-Smad (p38 MAPK) pathways; it cooperates with the co-receptor Ror2 (forming a ligand-independent BMPR-IB/Ror2 complex that is transphosphorylated to modulate Smad and Smad-independent outputs), is antagonized by NOGGIN via an interface including residue N445 (mutations here confer NOGGIN resistance and gain-of-function joint fusions), and is blocked by DAN-family members (e.g., Gremlin-2, whose crystal structure shows simultaneous occlusion of type I and II receptor sites); its expression in joints is driven by an array of modular enhancers distributed over >100 kb and is regulated transcriptionally by SP1, SP3, DEAF-1, and SOX11 and epigenetically by CpG methylation at the OA-susceptibility SNP rs143383 locus, with the OA-risk T allele showing reduced promoter activity and joint-wide expression; GDF5 promotes mesenchymal cell condensation, chondroprogenitor aggregation, chondrogenesis, joint interzone specification (via a continuous influx of Gdf5-lineage progenitors), collagen fibril maturation in tendons and ligaments, and dopaminergic neuron survival via Smad1/5/8 signaling."},"narrative":{"teleology":[{"year":1997,"claim":"Establishing that GDF5 processing and secretion are essential for function: a dominant-negative cysteine-to-tyrosine mutation in the mature domain blocked secretion and trapped wild-type BMPs via heterodimer formation, revealing prodomain processing and disulfide-dependent folding as critical for ligand activity.","evidence":"In vitro secretion and co-expression assays in transfected cells","pmids":["9288098"],"confidence":"High","gaps":["No structural basis for heterodimer-mediated trapping","Dominant-negative mechanism not tested in vivo"]},{"year":1999,"claim":"Defining GDF5 as both necessary and sufficient for cartilage formation and joint patterning resolved the fundamental question of its developmental role: brachypodism mice showed skeletal deficits while exogenous GDF5 induced ectopic cartilage and restricted joint sites across species.","evidence":"Brachypodism mouse genetics, recombinant GDF5 application to chick and mouse limb explants; transgenic overexpression in mice","pmids":["10208739","9885252"],"confidence":"High","gaps":["How GDF5 restricts versus promotes joint formation at the molecular level remained unclear","Downstream transcriptional targets not identified"]},{"year":2004,"claim":"Revealing how GDF5 promotes early chondrogenesis through cell adhesion-mediated condensation, distinct from BMP4 which drives internodular chondrogenesis, established that GDF5 acts at a specific stage — progenitor aggregation — and sustains Sox9 to a greater extent.","evidence":"Mouse embryonic limb micromass cultures comparing GDF5 versus BMP4 effects on condensation, Sox9, and Col10","pmids":["15048875","11263662"],"confidence":"Medium","gaps":["Adhesion molecules downstream of GDF5 not identified","Whether Sox9 is a direct transcriptional target of GDF5-Smad signaling was not tested"]},{"year":2004,"claim":"Identifying Ror2 as a co-receptor that forms a ligand-independent complex with BMPR-IB and is transphosphorylated by it answered how GDF5 activates both Smad and Smad-independent pathways during chondrogenesis, with Ror2 acting as a molecular switch between these outputs.","evidence":"Reciprocal Co-IP, transphosphorylation assays, luciferase reporters, and genetic epistasis using Ror2/BMPR-IB/Gdf5-deficient mouse crosses","pmids":["15569154"],"confidence":"High","gaps":["Identity of the Smad-independent pathway downstream of Ror2 not fully resolved","Structural basis for the BMPR-IB/Ror2 complex unknown"]},{"year":2005,"claim":"Pinpointing Arg57 as the single residue conferring GDF5's 12-fold selectivity for BMPR-IB over BMPR-IA resolved how GDF5 achieves receptor specificity within the BMP family despite high structural homology.","evidence":"SPR binding analysis, structural modeling, and R57A mutagenesis","pmids":["15890363"],"confidence":"High","gaps":["No crystal structure of the GDF5–BMPR-IB complex at that time","How receptor selectivity translates to distinct biological outputs in vivo not tested"]},{"year":2006,"claim":"Demonstrating GDF5's role in collagen fibril maturation — increasing fibril diameter and shifting procollagen type ratios — extended its function beyond cartilage to tendon and ligament repair.","evidence":"GDF5-null mouse tendon ultrastructure (EM), rat MCL injury model with GDF5 treatment and biomechanical testing","pmids":["11913489","16419971"],"confidence":"Medium","gaps":["Direct molecular target of GDF5 in collagen fibril assembly not identified","Whether effect is Smad-dependent unknown"]},{"year":2007,"claim":"Identifying the rs143383 T allele as reducing GDF5 promoter activity in chondrogenic cells and joint cartilage in vivo established the first direct mechanistic link between reduced GDF5 expression and osteoarthritis susceptibility.","evidence":"Luciferase reporter assays in chondrogenic cells, allelic expression analysis in OA patient articular cartilage","pmids":["17384641","17616513"],"confidence":"High","gaps":["Trans-acting factors mediating allelic differential expression not yet identified at this point","Whether reduced GDF5 is causal versus correlative for OA progression"]},{"year":2008,"claim":"Showing that GDF5 signals through BMPR-IB to activate p38 MAPK and upregulate the transcription factor Trps1 identified a non-Smad effector branch that promotes chondrocyte differentiation and apoptosis.","evidence":"ATDC5 cells treated with GDF5, dominant-negative Alk6, SB203580 inhibitor, western blot","pmids":["18363966"],"confidence":"Medium","gaps":["Direct Trps1 target genes downstream not identified","Whether p38-Trps1 axis operates in vivo during joint development unknown"]},{"year":2009,"claim":"Mapping GDF5 mutations (N445K/T) to the overlapping NOGGIN/receptor interface revealed that gain-of-function joint fusions in multiple synostosis syndrome arise from antagonist resistance rather than enhanced receptor binding, establishing a unified structure–function model for disease mutations.","evidence":"Chicken micromass chondrogenesis, in vivo chick ectopic expression, site-directed mutagenesis, BMP9 variant engineering","pmids":["19956691"],"confidence":"High","gaps":["Crystal structure of GDF5–NOGGIN complex not available","Whether all SYNS mutations share the same NOGGIN-resistance mechanism"]},{"year":2012,"claim":"The S94N mutation in the BMPR-II binding knuckle epitope showed simultaneous loss of receptor and antagonist binding, demonstrating that a single amino acid can produce context-dependent gain- or loss-of-function depending on the tissue's balance of receptor versus antagonist availability.","evidence":"SPR, reporter assays, ATDC5 and mouse micromass chondrogenesis assays","pmids":["21976273"],"confidence":"High","gaps":["Quantitative modeling of receptor-versus-antagonist balance in specific tissues not done"]},{"year":2013,"claim":"Identification of SP1, SP3, and DEAF-1 as allele-differential repressors of GDF5 at rs143383, with DEAF-1 preferentially repressing the T allele, provided the trans-acting mechanism underlying the OA-susceptibility expression difference.","evidence":"Competition/supershift EMSA, oligonucleotide pulldown with quantitative MS, ChIP, RNAi, and overexpression","pmids":["23825960","19565498"],"confidence":"High","gaps":["How SP1/DEAF-1 cooperate at the chromatin level not structurally resolved","Whether these factors explain allelic imbalance across all joint tissues"]},{"year":2013,"claim":"The W414R dual-mechanism mutation showed simultaneous NOGGIN resistance (causing SYNS2) and reduced BMPR-IA signaling (causing BDA1), proving that a single GDF5 residue can independently modulate antagonist and receptor interactions to produce composite phenotypes.","evidence":"Primary mesenchymal cell chondrogenesis, luciferase reporters, SPR","pmids":["24098149"],"confidence":"High","gaps":["Whether therapeutic rescue of one arm (antagonist or receptor) suffices to correct the phenotype"]},{"year":2014,"claim":"CpG methylation at the +37 site within the SP1/SP3 binding footprint modulates allele-specific transcription factor binding and attenuates repression of GDF5, with differential methylation between hip and knee cartilage potentially explaining joint-site-specific OA susceptibility.","evidence":"Bisulfite sequencing, demethylation treatment, EMSA, luciferase reporters, comparative hip/knee methylation","pmids":["24861163","21642387"],"confidence":"High","gaps":["Causal role of +37 methylation in OA onset not proven in vivo","Which methyltransferases set joint-specific methylation patterns at the GDF5 locus"]},{"year":2016,"claim":"Resolution of the Gremlin-2–GDF5 crystal structure at 2.9 Å showed how DAN-family antagonists use a conformationally dynamic N-terminus to simultaneously occlude type I and type II receptor sites, revealing a mechanistically distinct inhibition mode from NOGGIN.","evidence":"X-ray crystallography, SPR, structural comparison with NOGGIN mechanism","pmids":["27524626"],"confidence":"High","gaps":["No in vivo evidence for Gremlin-2 as a physiological GDF5 antagonist in joint tissues","Whether DAN-family antagonism is relevant in joint disease"]},{"year":2016,"claim":"Genetic lineage tracing with Gdf5-CreERT2 demonstrated that joints form through continuous influx of Gdf5-expressing progenitors into the interzone over time, rather than from a single founder population, redefining the cellular mechanism of joint morphogenesis.","evidence":"Knockin Gdf5-CreERT2 mouse with temporal Cre activation and tdTomato reporter","pmids":["27292641"],"confidence":"High","gaps":["Signals directing Gdf5-lineage progenitor influx not identified","Whether the same mechanism operates in synovial joint repair in adults"]},{"year":2016,"claim":"Systematic enhancer mapping revealed that GDF5's joint-specific expression is controlled by modular enhancers distributed over >100 kb, with distinct elements driving axial versus limb joint expression, and a downstream GROW1 enhancer required for growth plate expression and normal bone length.","evidence":"Transgenic mouse enhancer survey, functional rescue assays; GROW1 knockout and enhancer activity assays","pmids":["27902701","28671685"],"confidence":"High","gaps":["Transcription factors acting through individual enhancers largely unidentified","How enhancer–promoter looping is organized across the >100-kb locus"]},{"year":null,"claim":"Major unresolved questions include the structural basis of the GDF5–BMPR-IB complex, the identity of adhesion molecules mediating GDF5-driven mesenchymal condensation, the in vivo relevance of DAN-family antagonism at joints, and the mechanism by which the >100-kb enhancer landscape is coordinately regulated across different joint types.","evidence":"","pmids":[],"confidence":"Low","gaps":["No GDF5–BMPR-IB co-crystal structure","Adhesion molecules downstream of GDF5 in condensation unknown","Enhancer-promoter 3D topology at the Gdf5 locus not mapped"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0048018","term_label":"receptor ligand activity","supporting_discovery_ids":[0,1,8]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[3,23]}],"localization":[{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[2,25,26]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,3,11,12,24]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[1,8,9,10,22]},{"term_id":"R-HSA-1474244","term_label":"Extracellular matrix organization","supporting_discovery_ids":[32,33]}],"complexes":[],"partners":["BMPR1B","BMPR1A","BMPR2","ROR2","NOG","GREM2","SP1","DEAF1"],"other_free_text":[]},"mechanistic_narrative":"GDF5 is a secreted BMP-family ligand that orchestrates skeletal patterning, joint formation, connective tissue maturation, and chondrogenic differentiation by signaling primarily through BMPR-IB — to which a single residue, Arg57, confers ~12-fold binding selectivity over BMPR-IA — activating canonical Smad1/5/8 and non-canonical p38 MAPK pathways, and cooperating with the co-receptor Ror2 to modulate Smad-dependent versus Smad-independent outputs required for chondrogenesis [PMID:15890363, PMID:15569154, PMID:18363966]. GDF5 promotes mesenchymal cell condensation and chondroprogenitor aggregation through increased cell adhesion, sustains Sox9 expression to drive cartilage differentiation, specifies joint interzones via continuous recruitment of Gdf5-lineage progenitors, and regulates collagen fibril assembly in tendons and ligaments [PMID:11263662, PMID:10208739, PMID:27292641, PMID:11913489]. Its activity is tightly controlled by extracellular antagonists — NOGGIN and DAN-family members such as Gremlin-2, which occlude overlapping receptor-binding epitopes — and disease-causing mutations at the antagonist/receptor interface (N445K/T, W414R, S94N) produce gain-of-function joint fusions (multiple synostosis syndrome) or loss-of-function brachydactyly through dual pathomechanisms [PMID:19956691, PMID:24098149, PMID:21976273, PMID:27524626]. Transcription of GDF5 is regulated by an array of modular enhancers spanning >100 kb, by the transcription factors SP1, SP3, DEAF-1, and SOX11, and by CpG methylation at the OA-susceptibility SNP rs143383, where the risk T allele shows reduced promoter activity and diminished joint expression, establishing a direct genetic link to osteoarthritis susceptibility [PMID:17384641, PMID:17616513, PMID:23825960, PMID:24861163, PMID:27902701]."},"prefetch_data":{"uniprot":{"accession":"P43026","full_name":"Growth/differentiation factor 5","aliases":["Bone morphogenetic protein 14","BMP-14","Cartilage-derived morphogenetic protein 1","CDMP-1","Lipopolysaccharide-associated protein 4","LAP-4","LPS-associated protein 4","Radotermin"],"length_aa":501,"mass_kda":55.4,"function":"Growth factor involved in bone and cartilage formation. During cartilage development regulates differentiation of chondrogenic tissue through two pathways. Firstly, positively regulates differentiation of chondrogenic tissue through its binding of high affinity with BMPR1B and of less affinity with BMPR1A, leading to induction of SMAD1-SMAD5-SMAD8 complex phosphorylation and then SMAD protein signaling transduction (PubMed:15530414, PubMed:21976273, PubMed:24098149, PubMed:25092592). Secondly, negatively regulates chondrogenic differentiation through its interaction with NOG (PubMed:21976273). Required to prevent excessive muscle loss upon denervation. This function requires SMAD4 and is mediated by phosphorylated SMAD1/5/8 (By similarity). Binds bacterial lipopolysaccharide (LPS) and mediates LPS-induced inflammatory response, including TNF secretion by monocytes (PubMed:11276205)","subcellular_location":"Secreted; Cell membrane","url":"https://www.uniprot.org/uniprotkb/P43026/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/GDF5","classification":"Not Classified","n_dependent_lines":3,"n_total_lines":1208,"dependency_fraction":0.0024834437086092716},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/GDF5","total_profiled":1310},"omim":[{"mim_id":"616849","title":"BRACHYDACTYLY, TYPE A1, D; BDA1D","url":"https://www.omim.org/entry/616849"},{"mim_id":"616145","title":"CATEL-MANZKE SYNDROME; CATMANS","url":"https://www.omim.org/entry/616145"},{"mim_id":"615866","title":"INTELLECTUAL DEVELOPMENTAL DISORDER WITH MICROCEPHALY AND WITH OR WITHOUT OCULAR MALFORMATIONS OR HYPOGONADOTROPIC HYPOGONADISM; IDDMOH","url":"https://www.omim.org/entry/615866"},{"mim_id":"615298","title":"SYMPHALANGISM, PROXIMAL, 1B; SYM1B","url":"https://www.omim.org/entry/615298"},{"mim_id":"615072","title":"BRACHYDACTYLY, TYPE A1, C; BDA1C","url":"https://www.omim.org/entry/615072"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"salivary gland","ntpm":9.3}],"url":"https://www.proteinatlas.org/search/GDF5"},"hgnc":{"alias_symbol":["CDMP1","BMP14"],"prev_symbol":[]},"alphafold":{"accession":"P43026","domains":[{"cath_id":"2.60.120.970","chopping":"200-247_261-347","consensus_level":"medium","plddt":86.9316,"start":200,"end":347},{"cath_id":"2.10.90.10","chopping":"355-378_397-501","consensus_level":"high","plddt":88.176,"start":355,"end":501}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P43026","model_url":"https://alphafold.ebi.ac.uk/files/AF-P43026-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P43026-F1-predicted_aligned_error_v6.png","plddt_mean":70.0},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=GDF5","jax_strain_url":"https://www.jax.org/strain/search?query=GDF5"},"sequence":{"accession":"P43026","fasta_url":"https://rest.uniprot.org/uniprotkb/P43026.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P43026/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P43026"}},"corpus_meta":[{"pmid":"17384641","id":"PMC_17384641","title":"A functional polymorphism in the 5' UTR of GDF5 is associated with susceptibility to osteoarthritis.","date":"2007","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17384641","citation_count":370,"is_preprint":false},{"pmid":"18193045","id":"PMC_18193045","title":"Common variants in the GDF5-UQCC region are associated with variation in human height.","date":"2008","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18193045","citation_count":315,"is_preprint":false},{"pmid":"10208739","id":"PMC_10208739","title":"GDF5 coordinates bone and joint formation during digit development.","date":"1999","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/10208739","citation_count":309,"is_preprint":false},{"pmid":"9288098","id":"PMC_9288098","title":"Disruption of human limb morphogenesis by a dominant negative mutation in CDMP1.","date":"1997","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9288098","citation_count":270,"is_preprint":false},{"pmid":"17616513","id":"PMC_17616513","title":"An SNP in the 5'-UTR of GDF5 is associated with osteoarthritis susceptibility in Europeans and with in vivo differences in allelic expression in articular cartilage.","date":"2007","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17616513","citation_count":167,"is_preprint":false},{"pmid":"9885252","id":"PMC_9885252","title":"Role of CDMP-1 in skeletal morphogenesis: promotion of mesenchymal cell recruitment and chondrocyte differentiation.","date":"1999","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/9885252","citation_count":147,"is_preprint":false},{"pmid":"25377511","id":"PMC_25377511","title":"TGF-β1, GDF-5, and BMP-2 stimulation induces chondrogenesis in expanded human articular chondrocytes and marrow-derived stromal cells.","date":"2015","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/25377511","citation_count":127,"is_preprint":false},{"pmid":"11263662","id":"PMC_11263662","title":"Growth/differentiation factor-5 (GDF-5) and skeletal development.","date":"2001","source":"The Journal of bone and joint surgery. American volume","url":"https://pubmed.ncbi.nlm.nih.gov/11263662","citation_count":126,"is_preprint":false},{"pmid":"15890363","id":"PMC_15890363","title":"A single residue of GDF-5 defines binding specificity to BMP receptor IB.","date":"2005","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15890363","citation_count":125,"is_preprint":false},{"pmid":"27292641","id":"PMC_27292641","title":"Joint Development Involves a Continuous Influx of Gdf5-Positive Cells.","date":"2016","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/27292641","citation_count":119,"is_preprint":false},{"pmid":"15048875","id":"PMC_15048875","title":"Distinct functions of BMP4 and GDF5 in the regulation of chondrogenesis.","date":"2004","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15048875","citation_count":116,"is_preprint":false},{"pmid":"21436509","id":"PMC_21436509","title":"Tendon tissue engineering: adipose-derived stem cell and GDF-5 mediated regeneration using electrospun matrix systems.","date":"2011","source":"Biomedical materials (Bristol, England)","url":"https://pubmed.ncbi.nlm.nih.gov/21436509","citation_count":112,"is_preprint":false},{"pmid":"17545436","id":"PMC_17545436","title":"BMP-14 gene therapy increases tendon tensile strength in a rat model of Achilles tendon injury.","date":"2007","source":"The Journal of bone and joint surgery. American volume","url":"https://pubmed.ncbi.nlm.nih.gov/17545436","citation_count":95,"is_preprint":false},{"pmid":"21642387","id":"PMC_21642387","title":"Expression of the osteoarthritis-associated gene GDF5 is modulated epigenetically by DNA methylation.","date":"2011","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21642387","citation_count":95,"is_preprint":false},{"pmid":"19565498","id":"PMC_19565498","title":"Functional analysis of the osteoarthritis susceptibility-associated GDF5 regulatory polymorphism.","date":"2009","source":"Arthritis and rheumatism","url":"https://pubmed.ncbi.nlm.nih.gov/19565498","citation_count":92,"is_preprint":false},{"pmid":"12919870","id":"PMC_12919870","title":"GDF-5 deficiency in mice delays Achilles tendon healing.","date":"2003","source":"Journal of orthopaedic research : official publication of the Orthopaedic Research Society","url":"https://pubmed.ncbi.nlm.nih.gov/12919870","citation_count":92,"is_preprint":false},{"pmid":"17070126","id":"PMC_17070126","title":"Growth and differentiation factor-5 (GDF-5) stimulates osteogenic differentiation and increases vascular endothelial growth factor (VEGF) levels in fat-derived stromal cells in vitro.","date":"2006","source":"Bone","url":"https://pubmed.ncbi.nlm.nih.gov/17070126","citation_count":87,"is_preprint":false},{"pmid":"24861163","id":"PMC_24861163","title":"CpG methylation regulates allelic expression of GDF5 by modulating binding of SP1 and SP3 repressor proteins to the osteoarthritis susceptibility SNP rs143383.","date":"2014","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24861163","citation_count":85,"is_preprint":false},{"pmid":"15569154","id":"PMC_15569154","title":"Modulation of GDF5/BRI-b signalling through interaction with the tyrosine kinase receptor Ror2.","date":"2004","source":"Genes to cells : devoted to molecular & cellular mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/15569154","citation_count":80,"is_preprint":false},{"pmid":"28671685","id":"PMC_28671685","title":"Ancient selection for derived alleles at a GDF5 enhancer influencing human growth and osteoarthritis risk.","date":"2017","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/28671685","citation_count":79,"is_preprint":false},{"pmid":"15187242","id":"PMC_15187242","title":"Repair of articular cartilage defects in rabbits using CDMP1 gene-transfected autologous mesenchymal cells derived from bone marrow.","date":"2004","source":"Rheumatology (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/15187242","citation_count":78,"is_preprint":false},{"pmid":"24561281","id":"PMC_24561281","title":"GDF5 reduces MMP13 expression in human chondrocytes via DKK1 mediated canonical Wnt signaling inhibition.","date":"2014","source":"Osteoarthritis and cartilage","url":"https://pubmed.ncbi.nlm.nih.gov/24561281","citation_count":78,"is_preprint":false},{"pmid":"19956691","id":"PMC_19956691","title":"Mutations in GDF5 reveal a key residue mediating BMP inhibition by NOGGIN.","date":"2009","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19956691","citation_count":76,"is_preprint":false},{"pmid":"29550439","id":"PMC_29550439","title":"Heparin functionalization increases retention of TGF-β2 and GDF5 on biphasic silk fibroin scaffolds for tendon/ligament-to-bone tissue engineering.","date":"2018","source":"Acta biomaterialia","url":"https://pubmed.ncbi.nlm.nih.gov/29550439","citation_count":75,"is_preprint":false},{"pmid":"31660079","id":"PMC_31660079","title":"3D-bioprinting a genetically inspired cartilage scaffold with GDF5-conjugated BMSC-laden hydrogel and polymer for cartilage repair.","date":"2019","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/31660079","citation_count":70,"is_preprint":false},{"pmid":"26661057","id":"PMC_26661057","title":"TGF-β1 and GDF5 Act Synergistically to Drive the Differentiation of Human Adipose Stromal Cells toward Nucleus Pulposus-like Cells.","date":"2015","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/26661057","citation_count":68,"is_preprint":false},{"pmid":"15095821","id":"PMC_15095821","title":"Multiple effects of GDF-5 deficiency on skeletal tissues: implications for therapeutic bioengineering.","date":"2004","source":"Annals of biomedical engineering","url":"https://pubmed.ncbi.nlm.nih.gov/15095821","citation_count":67,"is_preprint":false},{"pmid":"18180771","id":"PMC_18180771","title":"Freeze-dried tendon allografts as tissue-engineering scaffolds for Gdf5 gene delivery.","date":"2008","source":"Molecular therapy : the journal of the American Society of Gene Therapy","url":"https://pubmed.ncbi.nlm.nih.gov/18180771","citation_count":66,"is_preprint":false},{"pmid":"19054821","id":"PMC_19054821","title":"Association of the DVWA and GDF5 polymorphisms with osteoarthritis in UK populations.","date":"2008","source":"Annals of the rheumatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/19054821","citation_count":64,"is_preprint":false},{"pmid":"12121354","id":"PMC_12121354","title":"Mutation in the cartilage-derived morphogenetic protein-1 (CDMP1) gene in a kindred affected with fibular hypoplasia and complex brachydactyly (DuPan syndrome).","date":"2002","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12121354","citation_count":64,"is_preprint":false},{"pmid":"31932746","id":"PMC_31932746","title":"Regulation of Gdf5 expression in joint remodelling, repair and osteoarthritis.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/31932746","citation_count":61,"is_preprint":false},{"pmid":"27902701","id":"PMC_27902701","title":"Heads, Shoulders, Elbows, Knees, and Toes: Modular Gdf5 Enhancers Control Different Joints in the Vertebrate Skeleton.","date":"2016","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27902701","citation_count":60,"is_preprint":false},{"pmid":"20633687","id":"PMC_20633687","title":"Evidence of association between GDF5 polymorphisms and congenital dislocation of the hip in a Caucasian population.","date":"2010","source":"Osteoarthritis and cartilage","url":"https://pubmed.ncbi.nlm.nih.gov/20633687","citation_count":59,"is_preprint":false},{"pmid":"11913489","id":"PMC_11913489","title":"GDF-5 deficiency in mice leads to disruption of tail tendon form and function.","date":"2001","source":"Connective tissue research","url":"https://pubmed.ncbi.nlm.nih.gov/11913489","citation_count":59,"is_preprint":false},{"pmid":"17656374","id":"PMC_17656374","title":"A novel dominant-negative mutation in Gdf5 generated by ENU mutagenesis impairs joint formation and causes osteoarthritis in mice.","date":"2007","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17656374","citation_count":55,"is_preprint":false},{"pmid":"24291420","id":"PMC_24291420","title":"Photo-cured hyaluronic acid-based hydrogels containing growth and differentiation factor 5 (GDF-5) for bone tissue regeneration.","date":"2013","source":"Bone","url":"https://pubmed.ncbi.nlm.nih.gov/24291420","citation_count":54,"is_preprint":false},{"pmid":"19029166","id":"PMC_19029166","title":"Genetic variation in the GDF5 region is associated with osteoarthritis, height, hip axis length and fracture risk: the Rotterdam study.","date":"2008","source":"Annals of the rheumatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/19029166","citation_count":54,"is_preprint":false},{"pmid":"30273415","id":"PMC_30273415","title":"Genome-wide association study of developmental dysplasia of the hip identifies an association with GDF5.","date":"2018","source":"Communications biology","url":"https://pubmed.ncbi.nlm.nih.gov/30273415","citation_count":54,"is_preprint":false},{"pmid":"14735582","id":"PMC_14735582","title":"Brachydactyly type C caused by a homozygous missense mutation in the prodomain of CDMP1.","date":"2004","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/14735582","citation_count":52,"is_preprint":false},{"pmid":"24388383","id":"PMC_24388383","title":"The effect of a bioactive collagen membrane releasing PDGF or GDF-5 on bone regeneration.","date":"2013","source":"Biomaterials","url":"https://pubmed.ncbi.nlm.nih.gov/24388383","citation_count":52,"is_preprint":false},{"pmid":"14669002","id":"PMC_14669002","title":"Release of active and depot GDF-5 after adenovirus-mediated overexpression stimulates rabbit and human intervertebral disc cells.","date":"2003","source":"Journal of molecular medicine (Berlin, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/14669002","citation_count":51,"is_preprint":false},{"pmid":"23825960","id":"PMC_23825960","title":"The identification of trans-acting factors that regulate the expression of GDF5 via the osteoarthritis susceptibility SNP rs143383.","date":"2013","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23825960","citation_count":51,"is_preprint":false},{"pmid":"12567410","id":"PMC_12567410","title":"Broad phenotypic spectrum caused by an identical heterozygous CDMP-1 mutation in three unrelated families.","date":"2003","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/12567410","citation_count":50,"is_preprint":false},{"pmid":"31482140","id":"PMC_31482140","title":"Genome-wide association study of knee pain identifies associations with GDF5 and COL27A1 in UK Biobank.","date":"2019","source":"Communications biology","url":"https://pubmed.ncbi.nlm.nih.gov/31482140","citation_count":49,"is_preprint":false},{"pmid":"23831389","id":"PMC_23831389","title":"BMP2 and GDF5 induce neuronal differentiation through a Smad dependant pathway in a model of human midbrain dopaminergic neurons.","date":"2013","source":"Molecular and cellular neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/23831389","citation_count":47,"is_preprint":false},{"pmid":"12124730","id":"PMC_12124730","title":"Frameshift mutation in the cartilage-derived morphogenetic protein 1 (CDMP1) gene and severe acromesomelic chondrodysplasia resembling Grebe-type chondrodysplasia.","date":"2002","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12124730","citation_count":46,"is_preprint":false},{"pmid":"30660009","id":"PMC_30660009","title":"Sustained release of GDF5 from a designed coacervate attenuates disc degeneration in a rat model.","date":"2019","source":"Acta biomaterialia","url":"https://pubmed.ncbi.nlm.nih.gov/30660009","citation_count":45,"is_preprint":false},{"pmid":"18283415","id":"PMC_18283415","title":"Novel point mutations in GDF5 associated with two distinct limb malformations in Chinese: brachydactyly type C and proximal symphalangism.","date":"2008","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18283415","citation_count":45,"is_preprint":false},{"pmid":"27524626","id":"PMC_27524626","title":"Structure of Gremlin-2 in Complex with GDF5 Gives Insight into DAN-Family-Mediated BMP Antagonism.","date":"2016","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/27524626","citation_count":41,"is_preprint":false},{"pmid":"27583982","id":"PMC_27583982","title":"MicroRNA-7 regulates IL-1β-induced extracellular matrix degeneration by targeting GDF5 in human nucleus pulposus cells.","date":"2016","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/27583982","citation_count":40,"is_preprint":false},{"pmid":"23356643","id":"PMC_23356643","title":"SOX11 contributes to the regulation of GDF5 in joint maintenance.","date":"2013","source":"BMC developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/23356643","citation_count":39,"is_preprint":false},{"pmid":"18363966","id":"PMC_18363966","title":"Trps1 plays a pivotal role downstream of Gdf5 signaling in promoting chondrogenesis and apoptosis of ATDC5 cells.","date":"2008","source":"Genes to cells : devoted to molecular & cellular mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/18363966","citation_count":39,"is_preprint":false},{"pmid":"23680368","id":"PMC_23680368","title":"Enhanced reconstruction of long bone architecture by a growth factor mutant combining positive features of GDF-5 and BMP-2.","date":"2013","source":"Biomaterials","url":"https://pubmed.ncbi.nlm.nih.gov/23680368","citation_count":37,"is_preprint":false},{"pmid":"22284607","id":"PMC_22284607","title":"Genetic association analysis of GDF5 and ADAM12 for knee osteoarthritis.","date":"2012","source":"Joint bone spine","url":"https://pubmed.ncbi.nlm.nih.gov/22284607","citation_count":36,"is_preprint":false},{"pmid":"16425226","id":"PMC_16425226","title":"Differential regulation of GDF-5 and FGF-2/4 by immobilisation in ovo exposes distinct roles in joint formation.","date":"2006","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/16425226","citation_count":36,"is_preprint":false},{"pmid":"19782107","id":"PMC_19782107","title":"GDF5 and BMP2 inhibit apoptosis via activation of BMPR2 and subsequent stabilization of XIAP.","date":"2009","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/19782107","citation_count":34,"is_preprint":false},{"pmid":"24098149","id":"PMC_24098149","title":"A GDF5 point mutation strikes twice--causing BDA1 and SYNS2.","date":"2013","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24098149","citation_count":33,"is_preprint":false},{"pmid":"21312163","id":"PMC_21312163","title":"Time kinetics of bone defect healing in response to BMP-2 and GDF-5 characterised by in vivo biomechanics.","date":"2011","source":"European cells & materials","url":"https://pubmed.ncbi.nlm.nih.gov/21312163","citation_count":33,"is_preprint":false},{"pmid":"16185246","id":"PMC_16185246","title":"The role of growth/differentiation factor 5 (GDF5) in the induction and survival of midbrain dopaminergic neurones: relevance to Parkinson's disease treatment.","date":"2005","source":"Journal of anatomy","url":"https://pubmed.ncbi.nlm.nih.gov/16185246","citation_count":32,"is_preprint":false},{"pmid":"36901991","id":"PMC_36901991","title":"Skeletal Muscle-Derived Exosomal miR-146a-5p Inhibits Adipogenesis by Mediating Muscle-Fat Axis and Targeting GDF5-PPARγ Signaling.","date":"2023","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/36901991","citation_count":32,"is_preprint":false},{"pmid":"35563063","id":"PMC_35563063","title":"Regulatory Mechanisms of Prg4 and Gdf5 Expression in Articular Cartilage and Functions in Osteoarthritis.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35563063","citation_count":32,"is_preprint":false},{"pmid":"27385596","id":"PMC_27385596","title":"Inhibition of microRNA-34a prevents IL-1β-induced extracellular matrix degradation in nucleus pulposus by increasing GDF5 expression.","date":"2016","source":"Experimental biology and medicine (Maywood, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/27385596","citation_count":32,"is_preprint":false},{"pmid":"28460412","id":"PMC_28460412","title":"MiR-615-3p inhibits the osteogenic differentiation of human lumbar ligamentum flavum cells via suppression of osteogenic regulators GDF5 and FOXO1.","date":"2017","source":"Cell biology international","url":"https://pubmed.ncbi.nlm.nih.gov/28460412","citation_count":31,"is_preprint":false},{"pmid":"31718857","id":"PMC_31718857","title":"microRNA-132 inhibits osteogenic differentiation of periodontal ligament stem cells via GDF5 and the NF-κB signaling pathway.","date":"2019","source":"Pathology, research and practice","url":"https://pubmed.ncbi.nlm.nih.gov/31718857","citation_count":30,"is_preprint":false},{"pmid":"16419971","id":"PMC_16419971","title":"Effect of GDF-5 on ligament healing.","date":"2006","source":"Journal of orthopaedic research : official publication of the Orthopaedic Research Society","url":"https://pubmed.ncbi.nlm.nih.gov/16419971","citation_count":30,"is_preprint":false},{"pmid":"30200326","id":"PMC_30200326","title":"Injured Achilles Tendons Treated with Adipose-Derived Stem Cells Transplantation and GDF-5.","date":"2018","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/30200326","citation_count":30,"is_preprint":false},{"pmid":"20937261","id":"PMC_20937261","title":"Combined use of bFGF and GDF-5 enhances the healing of medial collateral ligament injury.","date":"2010","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/20937261","citation_count":30,"is_preprint":false},{"pmid":"29761869","id":"PMC_29761869","title":"microRNA-665 promotes the proliferation and matrix degradation of nucleus pulposus through targeting GDF5 in intervertebral disc degeneration.","date":"2018","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/29761869","citation_count":30,"is_preprint":false},{"pmid":"23725396","id":"PMC_23725396","title":"Analysis of association between IL-1β, CASP-9, and GDF5 variants and low-back pain in Chinese male soldier: clinical article.","date":"2013","source":"Journal of neurosurgery. Spine","url":"https://pubmed.ncbi.nlm.nih.gov/23725396","citation_count":29,"is_preprint":false},{"pmid":"23226264","id":"PMC_23226264","title":"GDF5 regulates TGFß-dependent angiogenesis in breast carcinoma MCF-7 cells: in vitro and in vivo control by anti-TGFß peptides.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23226264","citation_count":28,"is_preprint":false},{"pmid":"16892395","id":"PMC_16892395","title":"A novel mutation in GDF5 causes autosomal dominant symphalangism in two Chinese families.","date":"2006","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/16892395","citation_count":28,"is_preprint":false},{"pmid":"29146735","id":"PMC_29146735","title":"Reduced Dnmt3a increases Gdf5 expression with suppressed satellite cell differentiation and impaired skeletal muscle regeneration.","date":"2018","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/29146735","citation_count":28,"is_preprint":false},{"pmid":"16014698","id":"PMC_16014698","title":"A mutation in the receptor binding site of GDF5 causes Mohr-Wriedt brachydactyly type A2.","date":"2005","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16014698","citation_count":27,"is_preprint":false},{"pmid":"19038017","id":"PMC_19038017","title":"A novel insertion mutation in the cartilage-derived morphogenetic protein-1 (CDMP1) gene underlies Grebe-type chondrodysplasia in a consanguineous Pakistani family.","date":"2008","source":"BMC medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19038017","citation_count":27,"is_preprint":false},{"pmid":"21976273","id":"PMC_21976273","title":"New insights into the molecular mechanism of multiple synostoses syndrome (SYNS): mutation within the GDF5 knuckle epitope causes noggin-resistance.","date":"2012","source":"Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research","url":"https://pubmed.ncbi.nlm.nih.gov/21976273","citation_count":27,"is_preprint":false},{"pmid":"16222676","id":"PMC_16222676","title":"Du Pan syndrome phenotype caused by heterozygous pathogenic mutations in CDMP1 gene.","date":"2005","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/16222676","citation_count":26,"is_preprint":false},{"pmid":"26739524","id":"PMC_26739524","title":"Adenovirus-mediated GDF-5 promotes the extracellular matrix expression in degenerative nucleus pulposus cells.","date":"2016","source":"Journal of Zhejiang University. Science. B","url":"https://pubmed.ncbi.nlm.nih.gov/26739524","citation_count":26,"is_preprint":false},{"pmid":"33231490","id":"PMC_33231490","title":"Knockout of miR-21-5p alleviates cartilage matrix degradation by targeting Gdf5 in temporomandibular joint osteoarthritis.","date":"2020","source":"Bone & joint research","url":"https://pubmed.ncbi.nlm.nih.gov/33231490","citation_count":26,"is_preprint":false},{"pmid":"15099634","id":"PMC_15099634","title":"Altered hypertrophic chondrocyte kinetics in GDF-5 deficient murine tibial growth plates.","date":"2004","source":"Journal of orthopaedic research : official publication of the Orthopaedic Research Society","url":"https://pubmed.ncbi.nlm.nih.gov/15099634","citation_count":26,"is_preprint":false},{"pmid":"31694926","id":"PMC_31694926","title":"An embryonic CaVβ1 isoform promotes muscle mass maintenance via GDF5 signaling in adult mouse.","date":"2019","source":"Science translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31694926","citation_count":25,"is_preprint":false},{"pmid":"22905146","id":"PMC_22905146","title":"Positive selection on the osteoarthritis-risk and decreased-height associated variants at the GDF5 gene in East Asians.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22905146","citation_count":24,"is_preprint":false},{"pmid":"38200442","id":"PMC_38200442","title":"Decellularized nucleus pulposus matrix/chitosan hybrid hydrogel combined with nucleus pulposus stem cells and GDF5-loaded microspheres for intervertebral disc degeneration prevention.","date":"2024","source":"Molecular medicine (Cambridge, Mass.)","url":"https://pubmed.ncbi.nlm.nih.gov/38200442","citation_count":24,"is_preprint":false},{"pmid":"25467786","id":"PMC_25467786","title":"Association between GDF5 rs143383 polymorphism and knee osteoarthritis: an updated meta-analysis based on 23,995 subjects.","date":"2014","source":"BMC musculoskeletal disorders","url":"https://pubmed.ncbi.nlm.nih.gov/25467786","citation_count":23,"is_preprint":false},{"pmid":"30116367","id":"PMC_30116367","title":"BMP14 induces tenogenic differentiation of bone marrow mesenchymal stem cells in vitro.","date":"2018","source":"Experimental and therapeutic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30116367","citation_count":23,"is_preprint":false},{"pmid":"14613311","id":"PMC_14613311","title":"Correlation of GDF5 and connexin 43 mRNA expression during embryonic development.","date":"2003","source":"The anatomical record. Part A, Discoveries in molecular, cellular, and evolutionary biology","url":"https://pubmed.ncbi.nlm.nih.gov/14613311","citation_count":22,"is_preprint":false},{"pmid":"23423687","id":"PMC_23423687","title":"Rs143383 in the growth differentiation factor 5 (GDF5) gene significantly associated with osteoarthritis (OA)-a comprehensive meta-analysis.","date":"2013","source":"International journal of medical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/23423687","citation_count":22,"is_preprint":false},{"pmid":"20683927","id":"PMC_20683927","title":"Mutations in GDF5 presenting as semidominant brachydactyly A1.","date":"2010","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/20683927","citation_count":22,"is_preprint":false},{"pmid":"24582800","id":"PMC_24582800","title":"Growth and differentiation factor-5 (GDF-5) in the human intervertebral annulus cells and its modulation by IL-1ß and TNF-α in vitro.","date":"2014","source":"Experimental and molecular pathology","url":"https://pubmed.ncbi.nlm.nih.gov/24582800","citation_count":22,"is_preprint":false},{"pmid":"27577507","id":"PMC_27577507","title":"Novel homozygous sequence variants in the GDF5 gene underlie acromesomelic dysplasia type-grebe in consanguineous families.","date":"2017","source":"Congenital anomalies","url":"https://pubmed.ncbi.nlm.nih.gov/27577507","citation_count":21,"is_preprint":false},{"pmid":"35346361","id":"PMC_35346361","title":"Long non-coding RNA SNHG5 promotes the osteogenic differentiation of bone marrow mesenchymal stem cells via the miR-212-3p/GDF5/SMAD pathway.","date":"2022","source":"Stem cell research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/35346361","citation_count":19,"is_preprint":false},{"pmid":"31338995","id":"PMC_31338995","title":"DNA hypermethylation of GDF5 in developmental dysplasia of the hip (DDH).","date":"2019","source":"Molecular genetics & genomic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31338995","citation_count":18,"is_preprint":false},{"pmid":"25320196","id":"PMC_25320196","title":"Superior angiogenic potential of GDF-5 and GDF-5(V453/V456) compared with BMP-2 in a rabbit long-bone defect model.","date":"2014","source":"The Journal of bone and joint surgery. American volume","url":"https://pubmed.ncbi.nlm.nih.gov/25320196","citation_count":18,"is_preprint":false},{"pmid":"30388100","id":"PMC_30388100","title":"The role of Gdf5 regulatory regions in development of hip morphology.","date":"2018","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/30388100","citation_count":18,"is_preprint":false},{"pmid":"24466161","id":"PMC_24466161","title":"Human chondrocytes respond discordantly to the protein encoded by the osteoarthritis susceptibility gene GDF5.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24466161","citation_count":18,"is_preprint":false},{"pmid":"25757091","id":"PMC_25757091","title":"Association of GDF5, SMAD3 and RUNX2 polymorphisms with temporomandibular joint osteoarthritis in female Han Chinese.","date":"2015","source":"Journal of oral rehabilitation","url":"https://pubmed.ncbi.nlm.nih.gov/25757091","citation_count":18,"is_preprint":false},{"pmid":"27030100","id":"PMC_27030100","title":"Mutant GDF5 enhances ameloblast differentiation via accelerated BMP2-induced Smad1/5/8 phosphorylation.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27030100","citation_count":18,"is_preprint":false},{"pmid":"21281725","id":"PMC_21281725","title":"Deep sequencing of GDF5 reveals the absence of rare variants at this important osteoarthritis susceptibility locus.","date":"2011","source":"Osteoarthritis and cartilage","url":"https://pubmed.ncbi.nlm.nih.gov/21281725","citation_count":17,"is_preprint":false},{"pmid":"19470416","id":"PMC_19470416","title":"Synergistic effects of growth and differentiation factor-5 (GDF-5) and insulin on expanded chondrocytes in a 3-D environment.","date":"2009","source":"Osteoarthritis and cartilage","url":"https://pubmed.ncbi.nlm.nih.gov/19470416","citation_count":17,"is_preprint":false},{"pmid":"12687891","id":"PMC_12687891","title":"Grebe dysplasia and the spectrum of CDMP1 mutations.","date":"2003","source":"Pediatric pathology & molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/12687891","citation_count":16,"is_preprint":false},{"pmid":"34203285","id":"PMC_34203285","title":"Genetic Study of IL6, GDF5 and PAPPA2 in Association with Developmental Dysplasia of the Hip.","date":"2021","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/34203285","citation_count":16,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":50728,"output_tokens":8221,"usd":0.137749},"stage2":{"model":"claude-opus-4-6","input_tokens":12019,"output_tokens":3939,"usd":0.237855},"total_usd":0.375604,"stage1_batch_id":"msgbatch_01DzrsgVgYngY1hvM3DU1yF2","stage2_batch_id":"msgbatch_01KA9b7iRzKFdhoBUT7vCvSe","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2005,\n      \"finding\": \"GDF5 shows pronounced binding specificity for BMPR-IB over BMPR-IA (approximately 12-fold higher affinity), and a single residue, Arg57 in the pre-helix loop, is solely responsible for this high binding specificity to BMPR-IB. The variant GDF5-R57A binds BMPR-IA and BMPR-IB with comparable high affinity.\",\n      \"method\": \"Biosensor analysis (SPR), structural analysis, and site-directed mutagenesis\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro binding assays with mutagenesis and structural validation in a single rigorous study\",\n      \"pmids\": [\"15890363\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"GDF5 is necessary and sufficient for both cartilage development and restriction of joint formation to appropriate locations in digit development. Loss-of-function brachypodism mice show reduced limb bone length, altered joint and sternum formation, and reduced digit bone number; recombinant GDF5 applied to developing chick and mouse limbs induces ectopic cartilage and restricts joint site.\",\n      \"method\": \"Mouse loss-of-function genetics (brachypodism mutant analysis), recombinant protein application to chick and mouse limb explants\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple genetic and functional rescue approaches, replicated across species\",\n      \"pmids\": [\"10208739\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"A dominant-negative mutation in CDMP1/GDF5 (substituting the first conserved cysteine in the mature domain with tyrosine) results in a protein that is not secreted, is inactive in vitro, and prevents secretion of other related BMP family members, likely through heterodimer formation.\",\n      \"method\": \"In vitro secretion assay, dominant-negative co-expression assay, heterodimer formation analysis\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro functional assays with mechanistic follow-up (heterodimer formation) in a well-cited study\",\n      \"pmids\": [\"9288098\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Ror2 (tyrosine kinase receptor) and BMPR-IB (BRI-b, serine/threonine kinase receptor) form a ligand-independent heteromeric complex requiring the frizzled-like CRD domain of Ror2. Within this complex, Ror2 is transphosphorylated by BRI-b. Ror2 modulates GDF5 signaling by inhibiting Smad1/5 signaling and activating a Smad-independent pathway, both required for chondrogenic differentiation.\",\n      \"method\": \"Co-immunoprecipitation, transphosphorylation assays, luciferase reporter assays (Smad pathway), dominant-negative constructs in ATDC5 cells, epistasis analysis in Ror2/BRI-b/Gdf5 deficient mouse crosses\",\n      \"journal\": \"Genes to cells\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP, functional signaling assays, and genetic epistasis across multiple orthogonal methods\",\n      \"pmids\": [\"15569154\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Two GDF5 mutations (N445K, N445T) identified in multiple synostosis syndrome patients cause resistance to the BMP antagonist NOGGIN due to substitution at residue N445, which lies within overlapping receptor and antagonist interfaces. This NOGGIN resistance results in gain-of-function, causing massive ectopic cartilage induction in vivo. Residue N445 is highly conserved among BMPs except BMP9 and BMP10, which naturally carry lysine at this position and are similarly NOGGIN-insensitive.\",\n      \"method\": \"Chicken micromass culture chondrogenesis assay, in vivo chick ectopic expression, site-directed mutagenesis, functional BMP9 variant engineering\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vitro and in vivo functional assays with mutagenesis and mechanistic follow-up\",\n      \"pmids\": [\"19956691\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"A GDF5 point mutation (W414R) simultaneously causes gain-of-function (NOGGIN resistance, leading to SYNS2) and loss-of-function (reduced signaling via BMPR-IA, leading to BDA1) through a dual pathomechanism, as the mutation lies within the overlapping antagonist and receptor binding interface of GDF5.\",\n      \"method\": \"Chondrogenesis assays with primary mesenchymal cells, luciferase reporter gene assays, Surface Plasmon Resonance (SPR) binding analysis\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple orthogonal quantitative methods (SPR, reporter assays, functional differentiation assays) in one study\",\n      \"pmids\": [\"24098149\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"The GDF5 mutation S94N, located in the BMPR-II interaction site (knuckle epitope), impairs BMPR-II binding, reduces Smad and non-Smad signaling, and decreases chondrogenic differentiation of ATDC5 cells, but causes gain-of-function in mouse micromass cultures due to strongly reduced affinity for the antagonist NOGGIN, resulting in the SYNS phenotype.\",\n      \"method\": \"SPR binding assays, reporter gene assays, ALP assay, qPCR, ATDC5 and mouse micromass chondrogenesis assays\",\n      \"journal\": \"Journal of bone and mineral research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple quantitative orthogonal methods establishing dual receptor and antagonist binding mechanism\",\n      \"pmids\": [\"21976273\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"The crystal structure of Gremlin-2 (a DAN-family BMP antagonist) in complex with GDF5 at 2.9-Å resolution reveals two Grem2 dimers binding perpendicularly to each GDF5 monomer in an H-like structure. The dynamic Grem2 N-terminus undergoes conformational change upon binding to simultaneously interact with both type I and type II receptor motifs on GDF5, blocking signaling. DAN-family members can interact with BMP type I receptor complexes, whereas Noggin outcompetes the type I receptor.\",\n      \"method\": \"X-ray crystallography (2.9-Å resolution), SPR binding studies, structural comparison\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure with binding validation and mechanistic comparison across antagonist families\",\n      \"pmids\": [\"27524626\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"GDF5 promotes chondroprogenitor cell aggregation by increasing cell adhesiveness and enhances skeletal element growth by increasing proliferation within epiphyseal cartilage. GDF5 acts at two distinct stages: promoting initial chondrogenesis via cell adhesion promotion, and increasing skeletal element size via proliferation.\",\n      \"method\": \"Chick embryo retroviral overexpression (RCAS), micromass and single-cell suspension cultures of limb mesenchymal cells, autoradiography of S-phase cells, histological analysis\",\n      \"journal\": \"The Journal of bone and joint surgery. American volume\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo overexpression combined with in vitro mechanistic studies showing cell adhesion increase\",\n      \"pmids\": [\"11263662\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"CDMP-1/GDF5 overexpression in transgenic mice promotes mesenchymal cell recruitment, increases number of chondroprogenitor cells, and accelerates chondrocyte differentiation to hypertrophy; expression in the notochord inhibits vertebral body formation by blocking sclerotome cell migration, antagonizing ventralization signals from the notochord.\",\n      \"method\": \"Transgenic mouse overexpression with histological and phenotypic analysis\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean transgenic gain-of-function with specific cellular phenotypic readouts\",\n      \"pmids\": [\"9885252\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"GDF5, in contrast to BMP4, increases the number of prechondrogenic mesenchymal cell condensations and promotes chondroprogenitor cell aggregation without inducing internodular cells toward chondrogenesis; GDF5 causes a more sustained elevation of Sox9 and a transient (not sustained) increase in Col10 expression, indicating distinct mechanisms from BMP4.\",\n      \"method\": \"Mouse embryonic limb bud mesenchyme micromass cultures with comparative BMP4/GDF5 treatment, gene expression analysis\",\n      \"journal\": \"Journal of cellular biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — systematic comparative functional study but single lab\",\n      \"pmids\": [\"15048875\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"GDF5 signals through the Alk6 (BMPR-IB) receptor to enhance Trps1 protein levels and p38 MAPK phosphorylation and nuclear translocation in chondrogenic cells; Trps1 acts downstream of GDF5 signaling to promote chondrocyte differentiation and apoptosis. Dominant-negative Alk6 blocks GDF5-induced Trps1 upregulation and differentiation.\",\n      \"method\": \"ATDC5 cell treatment with GDF5, dominant-negative Alk6 construct, SB203580 p38 inhibitor, western blot, Trps1 overexpression/knockdown\",\n      \"journal\": \"Genes to cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — epistasis with DN receptor and inhibitor, single lab\",\n      \"pmids\": [\"18363966\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"GDF5 and BMP2 prevent apoptosis induced by serum starvation in mouse embryonic fibroblasts via BMPR2, which stabilizes XIAP by stimulating BMPR2-XIAP interaction and reducing XIAP ubiquitination; increased XIAP then counteracts apoptosis by binding and inactivating activated caspases. This mechanism is independent of Smad and MAPK signaling.\",\n      \"method\": \"Cell viability assays, Co-IP (BMPR2-XIAP interaction), ubiquitination assays, caspase activity assays, BMPR2-deficient cell analysis\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP and functional mechanism established, single lab\",\n      \"pmids\": [\"19782107\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"The rs143383 T/C SNP in the 5' UTR of GDF5 (located in the core promoter) exerts allelic differences in transcriptional activity in chondrogenic cells, with the OA susceptibility T allele showing reduced promoter activity.\",\n      \"method\": \"Luciferase reporter assays in chondrogenic cell lines\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — functional reporter assays replicated across populations, highly cited foundational study\",\n      \"pmids\": [\"17384641\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"The OA-susceptibility T allele of rs143383 shows up to 27% reduction in GDF5 expression relative to the C allele in vivo in articular cartilage of OA patients, confirming that the functional effect of this regulatory SNP is active in joint tissue.\",\n      \"method\": \"Allelic expression analysis of RNA extracted from OA patient cartilage (in vivo differential allelic expression assay)\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct in vivo allelic expression quantification in patient tissue, replicates in vitro finding\",\n      \"pmids\": [\"17616513\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"The transcription factor DEAF-1 binds differentially to the two alleles of rs143383 in the GDF5 5'UTR and acts as a trans-acting repressor of GDF5 expression; a second polymorphism in the 3'UTR also independently influences allelic expression of GDF5.\",\n      \"method\": \"Electrophoretic mobility shift assay (EMSA), luciferase reporter assays, allelic expression analysis in multiple joint tissue types\",\n      \"journal\": \"Arthritis and rheumatism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — EMSA plus allelic expression, single lab\",\n      \"pmids\": [\"19565498\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Four trans-acting factors—Sp1, Sp3, P15, and DEAF-1—bind to the GDF5 5'UTR at the rs143383 locus. Sp1, Sp3, and DEAF-1 are repressors of GDF5 expression; DEAF-1 represses the T allele of rs143383 to a significantly greater extent than the C allele, contributing to differential allelic expression. Sp1 and DEAF-1 together have the greatest repressive activity.\",\n      \"method\": \"Competition and supershift EMSAs, oligonucleotide pulldown with quantitative mass spectrometry, ChIP, RNAi knockdown, and overexpression\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods including in vivo ChIP and MS identification, single lab\",\n      \"pmids\": [\"23825960\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"CpG methylation at the +37 site within the SP1/SP3 binding site modulates the allele-specific binding of SP1 and SP3 to rs143383, attenuating the repressive effects of SP1, SP3, and DEAF-1 on GDF5 promoter activity. The +37 CpG site is differentially methylated between osteoarthritic hip and knee cartilage, potentially explaining knee-specific OA susceptibility.\",\n      \"method\": \"Bisulfite sequencing, demethylation agent treatment, EMSA, luciferase reporter assays, comparative cartilage methylation analysis\",\n      \"journal\": \"Human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods establishing methylation-dependent allele-specific transcription factor binding\",\n      \"pmids\": [\"24861163\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"DNA methylation of the GDF5 promoter and 5'UTR regulates GDF5 expression; demethylation correlates with increased GDF5 expression. The CpG sites created by the C alleles at rs143383 and rs143384 are variably methylated, and demethylating agent treatment further increases allelic expression imbalance between C and T alleles.\",\n      \"method\": \"Bisulfite sequencing of cell lines and joint tissues, demethylating agent (5-azacytidine) treatment, allelic expression quantification\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — epigenetic mechanism established with demethylating agent experiment and in vivo tissue analysis\",\n      \"pmids\": [\"21642387\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"SOX11 directly binds conserved SOX family binding sites in the 5'UTR region of the GDF5 gene and activates GDF5 expression in vitro and in chick micromass cultures. SOX11 overexpression in developing chick limbs enhances (but does not ectopically induce) Gdf5 expression.\",\n      \"method\": \"Reporter gene assays, micromass cell cultures, chromatin binding assays (SOX11 binding to GDF5 5'UTR), RCAS viral overexpression in chick limbs\",\n      \"journal\": \"BMC developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — direct binding demonstrated with reporter assays and in vivo overexpression, single lab\",\n      \"pmids\": [\"23356643\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Separate modular enhancers in the Gdf5 locus control joint-specific expression in axial versus limb joints and in specific subsets of composite joints; predicted transcription factor binding sites within these enhancers are required for expression in particular joints. Functional rescue tests in mice confirm that large flanking regions (>100 kb including up- and downstream sequences) are required for normal joint formation and patterning.\",\n      \"method\": \"Systematic regulatory element survey using transgenic mice, in vivo enhancer functional rescue assays\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — systematic in vivo enhancer mapping with functional rescue in transgenic mice\",\n      \"pmids\": [\"27902701\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"A novel downstream regulatory region (GROW1) is required for normal Gdf5 expression at the ends of developing bones and for normal bone lengths in vivo. A human GROW1 common base-pair change decreases enhancer activity and colocalizes with peaks of positive selection; the derived allele is found in Neandertals and Denisovans.\",\n      \"method\": \"Transgenic mouse regulatory survey, in vivo Gdf5 expression analysis, enhancer activity assays\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo functional enhancer knockout and expression rescue in transgenic mice\",\n      \"pmids\": [\"28671685\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Joints develop through a continuous influx of Gdf5-positive cells into the interzone, which contribute differentially to forming joint tissues including articular cartilage, capsule, and ligaments. Early labeling of Gdf5-positive interzone cells fails to mark the entire joint organ, while multiple Cre activation steps show contribution to various compartments over time.\",\n      \"method\": \"Knockin Gdf5-CreERT2 mouse lineage tracing with temporal Cre activation steps and tdTomato reporter\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic lineage tracing with multiple temporal labeling steps and reporter, rigorous in vivo approach\",\n      \"pmids\": [\"27292641\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"GDF5 stimulation of human chondrocytes inhibits canonical Wnt signaling through upregulation of the Wnt inhibitors DKK1 and FRZB, and GDF5-mediated inhibition of MMP13 expression is specifically mediated by DKK1. GDF5 also upregulates anabolic genes ACAN and SOX9 and inhibits ADAMTS4.\",\n      \"method\": \"Human chondrocyte pellet mass culture, qPCR, ELISA, canonical Wnt stimulation (Wnt3a/CHIR-99021) and DKK1 blockade (WAY-262611) experiments\",\n      \"journal\": \"Osteoarthritis and cartilage\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological pathway dissection with multiple interventions, single lab\",\n      \"pmids\": [\"24561281\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"BMP2 and GDF5 induce neuronal differentiation (neurite outgrowth) of SH-SY5Y human neuronal cells via a direct mechanism dependent on BMP type I receptor activation of canonical Smad1/5/8 signaling.\",\n      \"method\": \"SH-SY5Y cell culture, neurite outgrowth assay, BMP receptor inhibition, Smad1/5/8 phosphorylation assay\",\n      \"journal\": \"Molecular and cellular neurosciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct signaling pathway established with receptor inhibition and Smad phosphorylation readout, single lab\",\n      \"pmids\": [\"23831389\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"A GDF5 mutation (p.L373R in the prodomain) allows secretion of mature GDF5 protein and causes proximal symphalangism (gain-of-function/altered function), while a different mutation (p.Y487X truncating the C-terminus) prevents secretion of mature GDF5 and causes brachydactyly type C (loss-of-function), demonstrating that distinct parts of the GDF5 protein govern distinct functional outcomes.\",\n      \"method\": \"Transfection of COS-7 cells with WT and mutant GDF5 cDNAs, western blot of conditioned medium for mature GDF5 protein detection\",\n      \"journal\": \"Journal of human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — in vitro secretion assay with two contrasting mutations, single method but clear mechanistic distinction\",\n      \"pmids\": [\"18283415\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"A novel ENU-induced GDF5 mutation (W408R) in a highly conserved region of the active signaling domain produces a protein that is secreted and dimerizes normally but inhibits wild-type GDF5 in a dominant-negative fashion, causing severe skeletal abnormalities and early-onset osteoarthritis in mice.\",\n      \"method\": \"ENU mutagenesis screen, secretion assay, dimerization assay, in vivo skeletal phenotyping including OA assessment\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — biochemical characterization of dominant-negative mechanism with in vivo phenotypic validation\",\n      \"pmids\": [\"17656374\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"TGF-β1 and GDF5 synergistically drive nucleopulpogenic differentiation of human adipose stromal cells; Smad2/3 signaling mainly governs acquisition of NP cell molecular identity while Smad1/5/8 controls NP cell morphology during this differentiation process.\",\n      \"method\": \"Human adipose stromal cell differentiation, gene expression analysis, Smad pathway inhibition, in vivo transplantation in nude mice\",\n      \"journal\": \"Stem cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — Smad pathway dissection with in vivo validation, single lab\",\n      \"pmids\": [\"26661057\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Gdf5 upregulation in articular cartilage and synovium following joint injury requires downstream regulatory sequence of the Gdf5 locus; in progenitors, Gdf5 expression is inversely correlated with YAP expression, and YAP overexpression suppresses Gdf5 expression in chondroprogenitors in vitro.\",\n      \"method\": \"Gdf5-LacZ reporter mouse lines, DMM experimental OA model, acute cartilage injury model, YAP overexpression in chondroprogenitors\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo reporter analysis combined with in vitro YAP overexpression functional test, single lab\",\n      \"pmids\": [\"31932746\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"CaVβ1E (an embryonic isoform of the CaV1.1 β subunit) boosts downstream GDF5 signaling to counteract muscle loss after denervation; aged muscle expresses lower CaVβ1E and shows an altered GDF5-dependent response to denervation. CaVβ1E overexpression improves mass wasting in aging muscle by increasing GDF5 expression.\",\n      \"method\": \"Sciatic denervation mouse model, Dnmt3a-KO mice, CaVβ1E overexpression, muscle mass and gene expression analysis\",\n      \"journal\": \"Science translational medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic loss- and gain-of-function with mechanistic link to GDF5, single lab\",\n      \"pmids\": [\"31694926\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Dnmt3a methylates the Gdf5 promoter in satellite cells; loss of Dnmt3a leads to reduced Gdf5 promoter methylation, markedly increased Gdf5 mRNA expression, suppressed satellite cell differentiation, and impaired skeletal muscle regeneration. Treatment with DNA methylation inhibitor azacytidine also increases Gdf5 expression in wild-type satellite cells.\",\n      \"method\": \"Skeletal muscle-specific Dnmt3a-KO mice, microarray analysis, promoter methylation analysis, azacytidine treatment, satellite cell differentiation assays\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO mouse model with methylation analysis and pharmacological validation, single lab\",\n      \"pmids\": [\"29146735\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"miR-7 directly targets GDF5 in nucleus pulposus cells; miR-7 overexpression enhances IL-1β-induced extracellular matrix degeneration, while inhibition of miR-7 prevents this, an effect that is reversed by GDF5 siRNA. This establishes GDF5 as a downstream mediator of miR-7 action on disc ECM.\",\n      \"method\": \"Dual-luciferase reporter assay (direct 3'UTR targeting), gain- and loss-of-function with miR-7 mimic/antagomiR, GDF5 siRNA rescue\",\n      \"journal\": \"Biomedicine & pharmacotherapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — direct 3'UTR luciferase validation plus functional rescue, single lab\",\n      \"pmids\": [\"27583982\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"GDF5 deficiency in mice results in altered collagen fibril size distribution (increased proportion of medium-diameter fibrils at the expense of larger fibrils) in tail tendons, leading to altered time-dependent mechanical behavior (slower stress-relaxation), suggesting GDF5 regulates collagen fibril assembly in tendon.\",\n      \"method\": \"Electron microscopy ultrastructural analysis, biomechanical testing of GDF5-/- vs. control littermate tail tendons\",\n      \"journal\": \"Connective tissue research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO mouse with ultrastructural and biomechanical phenotype, single lab\",\n      \"pmids\": [\"11913489\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"GDF5 treatment of rat medial collateral ligament injury increased collagen fibril diameter in repair tissue, enhanced type I procollagen expression, and reduced type III procollagen relative to type I, with decorin and fibromodulin expression also relatively reduced against type I collagen, explaining increased fibril diameter and improved biomechanical strength.\",\n      \"method\": \"Rat MCL gap injury model, transmission electron microscopy, quantitative PCR, in situ hybridization, biomechanical testing\",\n      \"journal\": \"Journal of orthopaedic research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo model with multi-method mechanistic readouts linking GDF5 to collagen fibril regulation\",\n      \"pmids\": [\"16419971\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"GDF5 regulates connexin 43 (Cx43) expression and enhances chondrogenesis in a gap junction-dependent manner, with concordant mRNA expression profiles of GDF5 and Cx43 during embryonic development in limb, spine, and heart.\",\n      \"method\": \"Expression correlation analysis during embryogenesis, functional studies linking GDF5 action to gap junction activity\",\n      \"journal\": \"The anatomical record\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — expression correlation with partial functional follow-up, single lab\",\n      \"pmids\": [\"14613311\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GDF5 is a secreted BMP-family ligand that signals primarily through BMPR-IB (with a single residue, Arg57, determining its high receptor-binding specificity) and BMPR-IA, activating canonical Smad1/5/8 and non-Smad (p38 MAPK) pathways; it cooperates with the co-receptor Ror2 (forming a ligand-independent BMPR-IB/Ror2 complex that is transphosphorylated to modulate Smad and Smad-independent outputs), is antagonized by NOGGIN via an interface including residue N445 (mutations here confer NOGGIN resistance and gain-of-function joint fusions), and is blocked by DAN-family members (e.g., Gremlin-2, whose crystal structure shows simultaneous occlusion of type I and II receptor sites); its expression in joints is driven by an array of modular enhancers distributed over >100 kb and is regulated transcriptionally by SP1, SP3, DEAF-1, and SOX11 and epigenetically by CpG methylation at the OA-susceptibility SNP rs143383 locus, with the OA-risk T allele showing reduced promoter activity and joint-wide expression; GDF5 promotes mesenchymal cell condensation, chondroprogenitor aggregation, chondrogenesis, joint interzone specification (via a continuous influx of Gdf5-lineage progenitors), collagen fibril maturation in tendons and ligaments, and dopaminergic neuron survival via Smad1/5/8 signaling.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"GDF5 is a secreted BMP-family ligand that orchestrates skeletal patterning, joint formation, connective tissue maturation, and chondrogenic differentiation by signaling primarily through BMPR-IB — to which a single residue, Arg57, confers ~12-fold binding selectivity over BMPR-IA — activating canonical Smad1/5/8 and non-canonical p38 MAPK pathways, and cooperating with the co-receptor Ror2 to modulate Smad-dependent versus Smad-independent outputs required for chondrogenesis [PMID:15890363, PMID:15569154, PMID:18363966]. GDF5 promotes mesenchymal cell condensation and chondroprogenitor aggregation through increased cell adhesion, sustains Sox9 expression to drive cartilage differentiation, specifies joint interzones via continuous recruitment of Gdf5-lineage progenitors, and regulates collagen fibril assembly in tendons and ligaments [PMID:11263662, PMID:10208739, PMID:27292641, PMID:11913489]. Its activity is tightly controlled by extracellular antagonists — NOGGIN and DAN-family members such as Gremlin-2, which occlude overlapping receptor-binding epitopes — and disease-causing mutations at the antagonist/receptor interface (N445K/T, W414R, S94N) produce gain-of-function joint fusions (multiple synostosis syndrome) or loss-of-function brachydactyly through dual pathomechanisms [PMID:19956691, PMID:24098149, PMID:21976273, PMID:27524626]. Transcription of GDF5 is regulated by an array of modular enhancers spanning >100 kb, by the transcription factors SP1, SP3, DEAF-1, and SOX11, and by CpG methylation at the OA-susceptibility SNP rs143383, where the risk T allele shows reduced promoter activity and diminished joint expression, establishing a direct genetic link to osteoarthritis susceptibility [PMID:17384641, PMID:17616513, PMID:23825960, PMID:24861163, PMID:27902701].\",\n  \"teleology\": [\n    {\n      \"year\": 1997,\n      \"claim\": \"Establishing that GDF5 processing and secretion are essential for function: a dominant-negative cysteine-to-tyrosine mutation in the mature domain blocked secretion and trapped wild-type BMPs via heterodimer formation, revealing prodomain processing and disulfide-dependent folding as critical for ligand activity.\",\n      \"evidence\": \"In vitro secretion and co-expression assays in transfected cells\",\n      \"pmids\": [\"9288098\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No structural basis for heterodimer-mediated trapping\", \"Dominant-negative mechanism not tested in vivo\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Defining GDF5 as both necessary and sufficient for cartilage formation and joint patterning resolved the fundamental question of its developmental role: brachypodism mice showed skeletal deficits while exogenous GDF5 induced ectopic cartilage and restricted joint sites across species.\",\n      \"evidence\": \"Brachypodism mouse genetics, recombinant GDF5 application to chick and mouse limb explants; transgenic overexpression in mice\",\n      \"pmids\": [\"10208739\", \"9885252\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How GDF5 restricts versus promotes joint formation at the molecular level remained unclear\", \"Downstream transcriptional targets not identified\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Revealing how GDF5 promotes early chondrogenesis through cell adhesion-mediated condensation, distinct from BMP4 which drives internodular chondrogenesis, established that GDF5 acts at a specific stage — progenitor aggregation — and sustains Sox9 to a greater extent.\",\n      \"evidence\": \"Mouse embryonic limb micromass cultures comparing GDF5 versus BMP4 effects on condensation, Sox9, and Col10\",\n      \"pmids\": [\"15048875\", \"11263662\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Adhesion molecules downstream of GDF5 not identified\", \"Whether Sox9 is a direct transcriptional target of GDF5-Smad signaling was not tested\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Identifying Ror2 as a co-receptor that forms a ligand-independent complex with BMPR-IB and is transphosphorylated by it answered how GDF5 activates both Smad and Smad-independent pathways during chondrogenesis, with Ror2 acting as a molecular switch between these outputs.\",\n      \"evidence\": \"Reciprocal Co-IP, transphosphorylation assays, luciferase reporters, and genetic epistasis using Ror2/BMPR-IB/Gdf5-deficient mouse crosses\",\n      \"pmids\": [\"15569154\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the Smad-independent pathway downstream of Ror2 not fully resolved\", \"Structural basis for the BMPR-IB/Ror2 complex unknown\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Pinpointing Arg57 as the single residue conferring GDF5's 12-fold selectivity for BMPR-IB over BMPR-IA resolved how GDF5 achieves receptor specificity within the BMP family despite high structural homology.\",\n      \"evidence\": \"SPR binding analysis, structural modeling, and R57A mutagenesis\",\n      \"pmids\": [\"15890363\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No crystal structure of the GDF5–BMPR-IB complex at that time\", \"How receptor selectivity translates to distinct biological outputs in vivo not tested\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Demonstrating GDF5's role in collagen fibril maturation — increasing fibril diameter and shifting procollagen type ratios — extended its function beyond cartilage to tendon and ligament repair.\",\n      \"evidence\": \"GDF5-null mouse tendon ultrastructure (EM), rat MCL injury model with GDF5 treatment and biomechanical testing\",\n      \"pmids\": [\"11913489\", \"16419971\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct molecular target of GDF5 in collagen fibril assembly not identified\", \"Whether effect is Smad-dependent unknown\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Identifying the rs143383 T allele as reducing GDF5 promoter activity in chondrogenic cells and joint cartilage in vivo established the first direct mechanistic link between reduced GDF5 expression and osteoarthritis susceptibility.\",\n      \"evidence\": \"Luciferase reporter assays in chondrogenic cells, allelic expression analysis in OA patient articular cartilage\",\n      \"pmids\": [\"17384641\", \"17616513\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Trans-acting factors mediating allelic differential expression not yet identified at this point\", \"Whether reduced GDF5 is causal versus correlative for OA progression\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Showing that GDF5 signals through BMPR-IB to activate p38 MAPK and upregulate the transcription factor Trps1 identified a non-Smad effector branch that promotes chondrocyte differentiation and apoptosis.\",\n      \"evidence\": \"ATDC5 cells treated with GDF5, dominant-negative Alk6, SB203580 inhibitor, western blot\",\n      \"pmids\": [\"18363966\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct Trps1 target genes downstream not identified\", \"Whether p38-Trps1 axis operates in vivo during joint development unknown\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Mapping GDF5 mutations (N445K/T) to the overlapping NOGGIN/receptor interface revealed that gain-of-function joint fusions in multiple synostosis syndrome arise from antagonist resistance rather than enhanced receptor binding, establishing a unified structure–function model for disease mutations.\",\n      \"evidence\": \"Chicken micromass chondrogenesis, in vivo chick ectopic expression, site-directed mutagenesis, BMP9 variant engineering\",\n      \"pmids\": [\"19956691\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Crystal structure of GDF5–NOGGIN complex not available\", \"Whether all SYNS mutations share the same NOGGIN-resistance mechanism\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"The S94N mutation in the BMPR-II binding knuckle epitope showed simultaneous loss of receptor and antagonist binding, demonstrating that a single amino acid can produce context-dependent gain- or loss-of-function depending on the tissue's balance of receptor versus antagonist availability.\",\n      \"evidence\": \"SPR, reporter assays, ATDC5 and mouse micromass chondrogenesis assays\",\n      \"pmids\": [\"21976273\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Quantitative modeling of receptor-versus-antagonist balance in specific tissues not done\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Identification of SP1, SP3, and DEAF-1 as allele-differential repressors of GDF5 at rs143383, with DEAF-1 preferentially repressing the T allele, provided the trans-acting mechanism underlying the OA-susceptibility expression difference.\",\n      \"evidence\": \"Competition/supershift EMSA, oligonucleotide pulldown with quantitative MS, ChIP, RNAi, and overexpression\",\n      \"pmids\": [\"23825960\", \"19565498\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How SP1/DEAF-1 cooperate at the chromatin level not structurally resolved\", \"Whether these factors explain allelic imbalance across all joint tissues\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"The W414R dual-mechanism mutation showed simultaneous NOGGIN resistance (causing SYNS2) and reduced BMPR-IA signaling (causing BDA1), proving that a single GDF5 residue can independently modulate antagonist and receptor interactions to produce composite phenotypes.\",\n      \"evidence\": \"Primary mesenchymal cell chondrogenesis, luciferase reporters, SPR\",\n      \"pmids\": [\"24098149\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether therapeutic rescue of one arm (antagonist or receptor) suffices to correct the phenotype\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"CpG methylation at the +37 site within the SP1/SP3 binding footprint modulates allele-specific transcription factor binding and attenuates repression of GDF5, with differential methylation between hip and knee cartilage potentially explaining joint-site-specific OA susceptibility.\",\n      \"evidence\": \"Bisulfite sequencing, demethylation treatment, EMSA, luciferase reporters, comparative hip/knee methylation\",\n      \"pmids\": [\"24861163\", \"21642387\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Causal role of +37 methylation in OA onset not proven in vivo\", \"Which methyltransferases set joint-specific methylation patterns at the GDF5 locus\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Resolution of the Gremlin-2–GDF5 crystal structure at 2.9 Å showed how DAN-family antagonists use a conformationally dynamic N-terminus to simultaneously occlude type I and type II receptor sites, revealing a mechanistically distinct inhibition mode from NOGGIN.\",\n      \"evidence\": \"X-ray crystallography, SPR, structural comparison with NOGGIN mechanism\",\n      \"pmids\": [\"27524626\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No in vivo evidence for Gremlin-2 as a physiological GDF5 antagonist in joint tissues\", \"Whether DAN-family antagonism is relevant in joint disease\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Genetic lineage tracing with Gdf5-CreERT2 demonstrated that joints form through continuous influx of Gdf5-expressing progenitors into the interzone over time, rather than from a single founder population, redefining the cellular mechanism of joint morphogenesis.\",\n      \"evidence\": \"Knockin Gdf5-CreERT2 mouse with temporal Cre activation and tdTomato reporter\",\n      \"pmids\": [\"27292641\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Signals directing Gdf5-lineage progenitor influx not identified\", \"Whether the same mechanism operates in synovial joint repair in adults\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Systematic enhancer mapping revealed that GDF5's joint-specific expression is controlled by modular enhancers distributed over >100 kb, with distinct elements driving axial versus limb joint expression, and a downstream GROW1 enhancer required for growth plate expression and normal bone length.\",\n      \"evidence\": \"Transgenic mouse enhancer survey, functional rescue assays; GROW1 knockout and enhancer activity assays\",\n      \"pmids\": [\"27902701\", \"28671685\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Transcription factors acting through individual enhancers largely unidentified\", \"How enhancer–promoter looping is organized across the >100-kb locus\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Major unresolved questions include the structural basis of the GDF5–BMPR-IB complex, the identity of adhesion molecules mediating GDF5-driven mesenchymal condensation, the in vivo relevance of DAN-family antagonism at joints, and the mechanism by which the >100-kb enhancer landscape is coordinately regulated across different joint types.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No GDF5–BMPR-IB co-crystal structure\", \"Adhesion molecules downstream of GDF5 in condensation unknown\", \"Enhancer-promoter 3D topology at the Gdf5 locus not mapped\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0048018\", \"supporting_discovery_ids\": [0, 1, 8]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [3, 23]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [2, 25, 26]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 3, 11, 12, 24]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [1, 8, 9, 10, 22]},\n      {\"term_id\": \"R-HSA-1474244\", \"supporting_discovery_ids\": [32, 33]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"BMPR1B\",\n      \"BMPR1A\",\n      \"BMPR2\",\n      \"ROR2\",\n      \"NOG\",\n      \"GREM2\",\n      \"SP1\",\n      \"DEAF1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}